Funded Tech Companies
Osteal Therapeutics
Headquartered in Dallas, Osteal Therapeutics has funding from Johnson & Johnson Development Corporation, Asteroid Partners and Prism Ventures.
Company Overview
Company Name
Osteal Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
PO BOX 140740 520
Dallas, TX 75214
USA
Dallas, TX 75214
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences. The lead product under development, VT-X7, is a drug-device combination product that has the potential to be the first FDA approved antibiotic therapy for local delivery to treat infected joint prosthesis. If approved, VT-X7 has the potential to improve outcomes and lower the cost of care for orthopedic surgeons and their patients by providing a faster, more reliable treatment option. VT-X7 has undergone extensive pre-clinical development and successfully completed a Phase 2 clinical trial in late 2020.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/25/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Thompson
Chief Technical Officer
Jude Paganelli
Co-Founder
Brian Beaubien
VP - Marketing
Todd Saunders
Company Investors
- Johnson & Johnson Development Corporation
- Asteroid Partners
- Prism Ventures
- MedVest Capital
- Gideon Strategic Partners
- HM Capital
Browse more funded tech companies:
Ostara Nutrient Recovery Technologies | Ostendio
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs